mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.3 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |